Impact of busulfan exposure stratification on transplant outcomes and immune reconstitution in children with severe aplastic anemia

BackgroundSevere aplastic anemia (SAA) is a life-threatening bone marrow failure disorder. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an established curative treatment for pediatric patients with SAA. Busulfan, a key component of conditioning regimens, has a narrow therapeutic...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Yanxiao Li, Xiaoying Zhai, Qianqian Zhang, Yile Zhao, Chenhong Jia
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2026-09-01
Sarja:	Frontiers in Pharmacology
Aiheet:	allogeneic hematopoietic stem cell transplantation busulfan children immune reconstitution pharmacokinetics severe aplastic anemia
Linkit:	https://www.frontiersin.org/articles/10.3389/fphar.2026.1897156/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!